Actively Recruiting

Phase 4
Age: 18Years - 70Years
All Genders
NCT03855046

Complex Treatment of a Chronic Anal Fissure

Led by State Scientific Centre of Coloproctology, Russian Federation · Updated on 2022-01-27

340

Participants Needed

7

Research Sites

165 weeks

Total Duration

On this page

Sponsors

S

State Scientific Centre of Coloproctology, Russian Federation

Lead Sponsor

S

St. Petersburg State Pavlov Medical University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is aimed at studying the efficacy and safety of treating chronic anal fissure with botulinum toxin versus lateral subcutaneous sphincterotomy.

CONDITIONS

Official Title

Complex Treatment of a Chronic Anal Fissure

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with chronic anal fissure
Not Eligible

You will not qualify if you...

  • Inflammatory diseases of the colon
  • Pectenosis
  • Previous surgical interventions on the anal canal
  • IV grade internal and external hemorrhoids
  • Rectal fistula
  • Severe somatic diseases at the decompensation stage
  • Pregnancy and lactation
  • Individual intolerance and hypersensitivity to botulinum toxin
  • Myasthenia gravis and myasthenia-like syndromes
  • Anal sphincter insufficiency

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

GBUZ MO "Lvovskaia Raionaia Bolnica"

Podolsk, Moscow Oblast, Russia, 142155

Actively Recruiting

2

Astrakhan State Medical University

Astrakhan, Russia

Actively Recruiting

3

Medical Center ON-CLINIC

Moscow, Russia, 119034

Actively Recruiting

4

SSCCRussia

Moscow, Russia, 123423

Actively Recruiting

5

City Clinical Hospital №24, Department of Health City of Moscow

Moscow, Russia

Actively Recruiting

6

St. Petersburg State Pavlov Medical University

Saint Petersburg, Russia

Actively Recruiting

7

Siberian State Medical University

Tomsk, Russia

Actively Recruiting

Loading map...

Research Team

E

Evgeny E. Zharkov, MD

CONTACT

R

Roman Yu. Khryukin, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here